8-K - Entrada Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On February 26, 2026, Entrada Therapeutics, Inc. announced its financial results for the quarter ended December 3

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits. The following exhibit relating to Item 2.02 of this Form 8-K shall be deemed to be furnished and not filed: 99.

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1